Don’t Stop Relieving: Journey’s DFD-29 Trounces Oracea In Reducing Rosacea Lesions

 
• By Alaric DeArment
  
Journey announced topline results from two Phase III rosacea trials • Source: Shutterstock

More from Clinical Trials

More from R&D